CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 149,555	$ 46,883
General and administrative	41,704	18,135
Total operating expenses	191,259	65,018
Loss from operations	(191,259)	(65,018)
Other income (expense):
Interest and other income (expense), net	4,300	59
Interest expense	(1,720)	(10)
Total other income, net	2,580	49
Net loss	(188,679)	(64,969)
Other comprehensive loss:
Unrealized loss on marketable securities	201	20
Comprehensive loss	$ (188,880)	$ (64,989)
Net loss per share attributable to common stockholders - basic	$ (5.19)	$ (145.55)
Net loss per share attributable to common stockholders - diluted	$ (5.19)	$ (145.55)
Weighted-average common shares outstanding - basic	36,355,758	446,379
Weighted-average common shares outstanding - diluted	36,355,758	446,379